Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. cut its stake in Molina Healthcare, Inc. (NYSE:MOH) by 8.8% in the fourth quarter, HoldingsChannel reports. The firm owned 11,204 shares of the company’s stock after selling 1,085 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Molina Healthcare were worth $4,048,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Molina Healthcare in the 3rd quarter valued at $30,000. Coppell Advisory Solutions Corp. purchased a new stake in Molina Healthcare during the 4th quarter worth about $34,000. VisionPoint Advisory Group LLC lifted its holdings in Molina Healthcare by 105.6% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after buying an additional 57 shares during the last quarter. Brown Brothers Harriman & Co. acquired a new position in shares of Molina Healthcare during the 1st quarter worth about $40,000. Finally, Raleigh Capital Management Inc. increased its holdings in shares of Molina Healthcare by 40.4% in the 3rd quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock valued at $41,000 after acquiring an additional 36 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the transaction, the director now directly owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock valued at $6,472,517 over the last three months. 1.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on MOH shares. StockNews.com downgraded Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. UBS Group increased their target price on shares of Molina Healthcare from $350.00 to $380.00 and gave the company a “neutral” rating in a research report on Thursday, December 21st. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Truist Financial upped their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. Finally, Wells Fargo & Company cut their target price on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating on the stock in a research report on Monday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $393.09.

Molina Healthcare Price Performance

Shares of MOH opened at $357.41 on Wednesday. The company has a market capitalization of $20.94 billion, a price-to-earnings ratio of 19.03, a price-to-earnings-growth ratio of 1.06 and a beta of 0.47. Molina Healthcare, Inc. has a fifty-two week low of $266.35 and a fifty-two week high of $423.92. The firm has a 50-day simple moving average of $395.21 and a 200-day simple moving average of $370.85. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.54 and a current ratio of 1.54.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $4.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.31 by $0.07. The company had revenue of $9.05 billion during the quarter, compared to analysts’ expectations of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the firm earned $4.10 EPS. On average, equities research analysts anticipate that Molina Healthcare, Inc. will post 23.62 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.